Sterile manufacturing specialist Symbiosis Pharmaceutical Services has appointed Joanne Anderson as its new Business Development Director to help drive its commercial growth.
The company has promoted Anderson to the role following three successful years with the Scotland-based pharmaceutical contract manufacturing organisation (CMO) and will join the management team. She will report to Chief Executive Colin MacKay.
Anderson's responsibilities will include the strategic and operational management of all sales and marketing activities for Symbiosis globally.
A qualified analytical chemist with an MBA, Anderson has worked in the biopharmaceutical outsourcing sector for almost 15 years and has spent the last eight specialising in the field of sterile injectable products for clinical trials and low volume commercial supply.
Symbiosis specialises in the sterile fill/finish of biologic and small molecule products into vials, which are either liquid or lyophilised formulations. The fast-growing CMO’s capabilities include the ability to handle and fill antibodies, proteins, peptides, nucleic acids, cytotoxic, cytostatic and highly potent APIs including ADCs along with conventional small molecules.